These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
519 related items for PubMed ID: 23904524
1. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z, Li C. Reproduction; 2013 Oct; 146(4):397-406. PubMed ID: 23904524 [Abstract] [Full Text] [Related]
2. The expression and functionality of stromal caveolin 1 in human adenomyosis. Zhao L, Zhou S, Zou L, Zhao X. Hum Reprod; 2013 May; 28(5):1324-38. PubMed ID: 23442759 [Abstract] [Full Text] [Related]
3. Metformin inhibits StAR expression in human endometriotic stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation. Xu JN, Zeng C, Zhou Y, Peng C, Zhou YF, Xue Q. J Clin Endocrinol Metab; 2014 Aug; 99(8):2795-803. PubMed ID: 24823468 [Abstract] [Full Text] [Related]
4. Human Adenomyosis Endometrium Stromal Cells Secreting More Nerve Growth Factor: Impact and Effect. Li Y, Zou S, Xia X, Zhang S. Reprod Sci; 2015 Sep; 22(9):1073-82. PubMed ID: 25519715 [Abstract] [Full Text] [Related]
5. Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway. Li MQ, Li HP, Meng YH, Wang XQ, Zhu XY, Mei J, Li DJ. Fertil Steril; 2012 Apr; 97(4):919-29. PubMed ID: 22265030 [Abstract] [Full Text] [Related]
14. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Zakikhani M, Blouin MJ, Piura E, Pollak MN. Breast Cancer Res Treat; 2010 Aug; 123(1):271-9. PubMed ID: 20135346 [Abstract] [Full Text] [Related]